LONDON--(BUSINESS WIRE)--
Ap19
FORM 8.3
IRISH TAKEOVER PANEL
DISCLOSURE UNDER RULE 8.3 OF THE IRISH TAKEOVER PANEL ACT, 1997, TAKEOVER RULES, 2013
DEALINGS BY PERSONS WITH INTERESTS IN RELEVANT SECURITIES REPRESENTING 1% OR MORE
1. KEY INFORMATION
Name of person dealing (Note 1) | Barclays PLC. | |
Company dealt in | WILLIS TOWERS WATSON PLC | |
Class of relevant security to which the | ORD | |
dealings being disclosed relate (Note 2) | ||
Date of dealing | 14 May 2021 |
2. INTERESTS AND SHORT POSITIONS
(a) Interests and short positions (following dealing) in the class of relevant security dealt in (Note 3)
Class of relevant security: | ORD | ||||
Long | Short | ||||
Number | (%) | Number | (%) | ||
(1) |
Relevant securities | ||||
1,661,447 |
1.29% |
171,010 |
0.13% |
||
|
|
|
|
||
(2) |
Derivatives (other than options): |
|
|
|
|
72,359 |
0.06% |
0 |
0.00% |
||
|
|
|
|
||
(3) |
Options and agreements to |
|
|
|
|
purchase/sell: | 6,100 |
0.00% |
6,100 |
0.00% |
|
|
|
|
|
||
TOTAL: |
|
|
|
|
|
1,739,906 |
1.35% |
177,110 |
0.14% |
||
(b) Interests and short positions in relevant securities of the company, other than the class dealt in (Note 3)
Class of relevant security: |
Long |
Short |
||||
|
Number |
|
(%) |
Number |
|
(%) |
(1) Relevant securities |
|
|
||||
(2) Derivatives (other than options) |
|
|
||||
(3) Options and agreements to purchase/sell |
|
|
||||
Total |
|
|
||||
|
Ap20
1. DEALINGS (Note 4)
(a) Purchases and sales
Purchase/sale | Number of relevant securities | Price per unit |
Purchase |
3 |
264.9400 USD |
Purchase |
4 |
265.3450 USD |
Purchase |
6 |
266.0650 USD |
Purchase |
11 |
265.1586 USD |
Purchase |
11 |
265.2700 USD |
Purchase |
12 |
265.3900 USD |
Purchase |
13 |
265.1684 USD |
Purchase |
14 |
265.2664 USD |
Purchase |
16 |
265.3137 USD |
Purchase |
16 |
265.1821 USD |
Purchase |
19 |
265.0365 USD |
Purchase |
23 |
265.2150 USD |
Purchase |
25 |
265.0496 USD |
Purchase |
34 |
264.9300 USD |
Purchase |
39 |
265.3097 USD |
Purchase |
98 |
264.7811 USD |
Purchase |
100 |
264.9500 USD |
Purchase |
100 |
265.9700 USD |
Purchase |
122 |
264.2000 USD |
Purchase |
200 |
265.0850 USD |
Purchase |
200 |
264.9750 USD |
Purchase |
203 |
265.9299 USD |
Purchase |
271 |
265.7570 USD |
Purchase |
433 |
264.9661 USD |
Purchase |
484 |
265.0065 USD |
Purchase |
793 |
265.6574 USD |
Purchase |
833 |
265.0744 USD |
Purchase |
1,036 |
264.9926 USD |
Purchase |
1,383 |
264.9981 USD |
Purchase |
1,600 |
265.5893 USD |
Purchase |
2,319 |
265.3311 USD |
Purchase |
2,398 |
265.3928 USD |
Purchase |
4,047 |
264.9945 USD |
Purchase |
5,211 |
265.5026 USD |
Purchase |
5,492 |
264.8500 USD |
Purchase |
18,559 |
265.0248 USD |
Purchase |
94,150 |
265.0000 USD |
Purchase |
130,200 |
265.1862 USD |
Sale |
1 |
264.9100 USD |
Sale |
2 |
263.3200 USD |
Sale |
3 |
263.6200 USD |
Sale |
4 |
265.5375 USD |
Sale |
17 |
265.6664 USD |
Sale |
18 |
265.4661 USD |
Sale |
21 |
265.4721 USD |
Sale |
21 |
265.4440 USD |
Sale |
22 |
265.6545 USD |
Sale |
22 |
265.7227 USD |
Sale |
23 |
265.7389 USD |
Sale |
25 |
265.6436 USD |
Sale |
27 |
265.7290 USD |
Sale |
30 |
265.5383 USD |
Sale |
100 |
265.9700 USD |
Sale |
100 |
265.1100 USD |
Sale |
225 |
265.2336 USD |
Sale |
233 |
265.0750 USD |
Sale |
400 |
265.0662 USD |
Sale |
600 |
265.6766 USD |
Sale |
601 |
265.0700 USD |
Sale |
603 |
265.2479 USD |
Sale |
630 |
265.7068 USD |
Sale |
733 |
265.0695 USD |
Sale |
1,082 |
265.0948 USD |
Sale |
1,275 |
264.8113 USD |
Sale |
1,795 |
265.2976 USD |
Sale |
1,795 |
265.4414 USD |
Sale |
3,163 |
265.5092 USD |
Sale |
6,180 |
265.5043 USD |
Sale |
6,400 |
265.6926 USD |
Sale |
7,752 |
264.8500 USD |
Sale |
16,460 |
264.9742 USD |
Sale |
29,350 |
265.6719 USD |
Sale |
94,000 |
265.0000 USD |
Sale |
100,000 |
264.9994 USD |
(b) Derivatives transactions (other than options transactions)
Product name, e.g. CFD |
Nature of transaction (Note 6) |
Number of relevant securities (Note 7) |
Price per unit (Note 5) |
|
|
|
|
(c) Options transactions in respect of existing relevant securities
(i) Writing, selling, purchasing or varying
Product name, e.g. call option |
Writing, selling, purchasing, varying etc. |
Number of securities to which the option relates (Note 7) |
Exercise price |
Type, e.g. American, European etc. |
Expiry date |
Option money paid/received per unit (Note 5) |
|
|
|
|
|
|
|
(ii) Exercising
Product name, e.g. call option |
Number of securities |
Exercise price per unit (Note 5) |
|
|
|
(d) Other dealings (including transactions in respect of new securities) (Note 4)
Nature of transaction (Note 8) |
Details |
Price per unit (if applicable) (Note 5) |
|
|
|
Ap21
2. OTHER INFORMATION
Agreements, arrangements or understandings relating to options or derivatives
Full details of any agreement, arrangement or understanding between the person disclosing and any other person relating to the voting rights of any relevant securities under any option referred to on this form or relating to the voting rights or future acquisition or disposal of any relevant securities to which any derivative referred to on this form is referenced. If none, this should be stated.
None
Is a Supplemental Form 8 (Open Positions) attached? | YES |
Date of disclosure: | 17 May 2021 |
Contact name: | Large Holdings Regulatory Operations |
Telephone number: | 020 3134 7213 |
If a connected EFM, name of offeree/offeror with which connected | |
If a connected EFM, state nature of connection |
Ap23
SUPPLEMENTAL FORM 8
IRISH TAKEOVER PANEL
DISCLOSURE UNDER RULE 8.1 AND RULE 8.3 OF THE IRISH TAKEOVER PANEL ACT, 1997, TAKEOVER RULES, 2013
DETAILS OF OPEN POSITIONS
(This form should be attached to Form 8.1(a) & (b)(i), Form 8.1(b)(ii) or Form 8.3, as appropriate)
OPEN POSITIONS (Note 1)
Product name | Written or | Number of | Exercise | Type | Expiry |
purchased | relevant securities | price | date | ||
to which the option | |||||
or derivative | |||||
relates | |||||
Put Options |
Purchased |
-100 |
220.0000 |
American |
Jul 16, 2021 |
Call Options |
Purchased |
100 |
240.0000 |
American |
Jul 16, 2021 |
Call Options |
Purchased |
6,000 |
220.0000 |
American |
Jul 16, 2021 |
Put Options |
Purchased |
-6,000 |
200.0000 |
American |
Jul 16, 2021 |
Notes
1. Where there are open option positions or open derivative positions (except for CFDs), full details should be given. Full details of any existing agreements to purchase or to sell must also be given on this form.
2. For all prices and other monetary amounts, the currency must be stated.
For full details of disclosure requirements, see Rule 8 of the Rules. If in doubt, consult the Panel.